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Background/purpose: Although advanced age has been associated with the incidence of Clostridium
difﬁcile infection (CDI), its relationship with disease severity remains inconclusive. The objective of this
study was to evaluate risk factors, speciﬁcally advanced age, which may be associated with the acqui-
sition of severe CDI.
Methods: A retrospective chart review at a Veterans Affairs Hospital was conducted on hospitalized
veterans aged  18 years with a positive stool toxin assay for Clostridium difﬁcile between May 2008 and
September 2012 (n ¼ 224). One hundred and sixty-one (72%) patients were in the mildemoderate
infection group and 63 (28%) patients in the severe infection group. The primary outcome was to
determine the effect of advanced age (70 years old) on the acquisition of severe CDI. The secondary
outcome was to identify other potential risk factors for severe CDI. Disease severity was classiﬁed ac-
cording to the criteria established in the 2010 Society for Healthcare Epidemiology of America/Infectious
Disease Society of America practice guidelines for CDI. Demographic and disease-speciﬁc data were
collected. A logistic regression model was used to identify characteristics predictive of disease severity.
Results: Our regression model found advanced age to be signiﬁcantly associated with severe CDI (odds
ratio 2.43, p  0.005, 95% conﬁdence interval 1.31e4.50). A larger proportion of veterans were diagnosed
with severe CDI in the intensive care unit (p ¼ 0.004). In addition, multiple antibiotic use (3) and
association with severe CDI was statistically signiﬁcant (34% mildemoderate vs. 48% severe, p ¼ 0.041).
The univariate analyses did not reveal any other characteristics predictive of disease severity.
Conclusion: Advanced age was associated with severe CDI. A prospective evaluation is warranted to
validate this ﬁnding. Efforts to identify patients at risk for severe CDI will be important as it may direct
treatment and positively affect outcomes.
Copyright © 2015, Asia Paciﬁc League of Clinical Gerontology & Geriatrics. Published by Elsevier Taiwan
LLC. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).1. Introduction
Clostridium difﬁcile, a Gram-positive, spore-forming, toxin-
producing anaerobic bacillus remains the leading cause of health
care associated infectious diarrhea accounting for 15e25% of anti-
biotic associated diarrhea cases and its incidence is dramatically
increasing.1,2 C. difﬁcile infection (CDI) is associated with a wideHines, IL 60141, USA.
Hines, IL 60141, USA.
), jeffrey.wieczorkiewicz@va.
inical Gerontology & Geriatrics. Pub
d/4.0/).spectrum of clinical disease presentation from mild diarrhea to
fulminant and fatal toxic colitis. The Society for Healthcare Epide-
miology of America (SHEA) and the Infectious Disease Society of
America (IDSA) have developed guidelines to direct treatment
based on severity of disease. The guidelines utilize laboratory pa-
rameters including white blood cell count (WBC) and serum
creatinine (SCr), as well as potential complications from CDI (hy-
potension, shock, ileus or toxic megacolon) to distinguish mild to
moderate disease from severe disease.1 The guidelines also identify
risk factors for CDI including advanced age (>64 years of age),
duration of hospitalization, previous exposure to antimicrobial
agents, exposure to chemotherapy, immunosuppression,lished by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND
Table 1
Excluded patients (other causes for diarrhea).
Total patients, n ¼ 59
No labs 8 (14)
Hyperthyroidism 2 (3)
Ulcerative colitis 6 (10)
Cytomegalovirus colitis 1 (2)
Colon cancer 11 (19)
Gastric cancer 2 (3)
Pancreatic cancer 3 (5)
IBD-D a 2 (3)
Diverticulitis 20 (34)
Malabsorption 2 (3)
Appendectomy 1 (2)
Olgilvie Syndrome 1 (2)
Data are presented as n (%).
a Irritable bowel disease-diarrhea.
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tube feedings), and acid suppressive therapy.1 Speciﬁc risk factors
for severe CDI as opposed to CDI in general are not differentiated in
the guidelines, however, studies that have evaluated possible risk
factors associated with severe CDI have been conducted.3,4 A few
retrospective studies have identiﬁed age >70 years old as an in-
dependent risk factor for severe disease.5e10 Of note, the SHEA/
IDSA guidelines have highlighted advanced age (>64 years of age)
being positively associated with incidence of CDI, however, its
relationship with severity remains undeﬁned as current literature
is conﬂicting. The primary objective of our study is to evaluate
advanced age (70 years of age) as a possible risk factor that may
predispose patients to severe CDI, as deﬁned by the SHEA/IDSA
guidelines, in a veteran population.
2. Methods
2.1. Study design and setting
This was a retrospective, cohort chart review at the Edward
Hines Jr. Veterans Affairs (VA) Hospital. This VA hospital is a tertiary
care, teaching hospital located in the Chicago, Illinois metropolitan
area, with approximately 500 beds for acute and long-term care,
serving >56,000 veterans. Eligible patients for screening were
identiﬁed via microbiology reports identifying patients with a
positive stool toxin assay for C. difﬁcile between January 2008 and
September 2012. Patients were then evaluated by review of their
electronic medical records in the VA Computerized Patient Record
System. Patients were eligible for inclusion in the study if theywere
aged 18 years, and had acute CDI symptoms including episodes of
diarrhea. Patients were excluded from the study if they had CDI
within the 3 months prior to the study period, were asymptomatic,
or had any other identiﬁed causes of diarrhea at the time of in-
clusion. Included patients were stratiﬁed into two group-
sdnonsevere CDI and severe CDI based on the SHEA/IDSA criteria.
At the time of symptom onset, patients with a SCr < 1.5 times the
baseline and WBC < 15,000 cells/uL were classiﬁed as a nonsevere
case, whereas those with SCr  1.5 times the baseline or WBC 
15,000 cells/uL were considered as having a severe case.
2.2. Measures
Data collection included demographic information (age, gender,
race), comorbid conditions, location within the hospital at the time
of diagnosis of CDI, previous (within the past 90 days) or concurrent
medications shown to be related to increased risk for CDI (antibi-
otics, acid suppressive therapy, steroids, antiperistaltic agents,
immunosuppressive agents, and enteral/parenteral nutrition),
classiﬁcation of CDI, complications of CDI, prior surgical or endo-
scopic procedures in the past 90 days, prior hospital admission in
the past 90 days, long-term care or nursing home stay during the
past 90 days, and laboratory parameters (SCr, WBC, albumin). This
study was approved by the Hines VA Institutional Review Board
and Research and Development Committee prior to the
commencement of data collection.
2.3. Outcomes
The primary outcome of the study was to determine risk factors,
speciﬁcally advanced age (70 years old), which may be associated
with severe CDI within a hospital veteran population. The sec-
ondary outcomes of the study were to identify other potential risk
factors for severe CDI, as well as compare outcomes between the
severe and nonsevere groups: speciﬁcally, the number of relapsed
CDI episodes within 60 days, treatment failures, deﬁned as signsand symptoms of CDI not resolving by the end of a 10e14-day
course of standard therapy, and mortality at 30 days and 90 days
were all evaluated. These outcomes were compared between the
severe and nonsevere groups.2.4. Statistical analysis
The baseline characteristics of the study population were
described using counts and percentages for categorical variables
and means and standard deviations for continuous variables. Dif-
ferences in demographics, clinical background, and laboratory data
between patients with and without severe CDI were analyzed using
t-test, chi-square tests, or Fisher's exact test. A logistic regression
model was created to evaluate independent associations between
disease severity and signiﬁcant clinical variables identiﬁed in our
univariate analyses.3. Results
A total of 283 patient charts were reviewed with 59 patients
being excluded (recent CDI or other causes of diarrhea identiﬁed;
Table 1) and 224 patients meeting the inclusion criteria. There was
a statistically signiﬁcant difference found in the primary outcome
of advanced age as a risk factor for the acquisition of severe CDI.
Patients aged  70 years comprised 43% of the total severe CDI
population and 23% of the nonsevere CDI population (Table 2,
p ¼ 0.004). Table 2 highlights the secondary endpoints of patient
demographics including ethnicity and gender, laboratory parame-
ters, previous healthcare exposure including prior hospitalization
or long-term care exposure, and hospital unit at the time of diag-
nosis. There were no statistically signiﬁcant differences found
when comparing patient demographics. Laboratory parameters
including WBC  15,000 cells/uL, SCr  1.5 times the baseline, and
albumin < 2.5 mg/dL were found to be statistically signiﬁcant for
severe CDI (p < 0.001). In terms of location at the time of diagnosis,
there was a higher proportion of patients with severe CDI in the
intensive care unit (ICU; p ¼ 0.004). There were no statistically
signiﬁcant differences when comparing medication use in the
preceding 90 days, including antibiotics and acid suppressives be-
tween the two groups (Table 2). A statistical signiﬁcant difference
in patients receiving three or more antibiotics was identiﬁed with
48% having severe CDI and 34% with nonsevere CDI (p ¼ 0.041).
Comorbidities did not play a factor in the severity of CDI. The
following clinically signiﬁcant variables were included in our lo-
gistic regressionmodel: age 70 years, proton-pump inhibitor use,
and use of three or more antibiotic (Table 3). This model controlled
for antibiotic and proton-pump inhibitor use and demonstrated
Table 2
Univariate analysis of patient characteristics for mild-moderate versus severe Clostridium difﬁcile associated diarrhea.
Mildemoderate CDI n ¼ 161 Severe CDI n ¼ 63 p
Mean age (y) 66.4 70.5 0.020
Age (y)
18e69 123 (77) 36 (57) 0.004 a
70 38 (23) 27 (43)
Gender
Male 155 (96) 62 (98) 0.676 a
Female 6 (4) 1 (2)
Race
Caucasian 112 (70) 45 (70) 0.096 a
African American 38 (24) 10 (15)
Asian/Paciﬁc Islander 0 (0) 2 (5)
Unknown 11 (6) 6 (10)
Laboratory parameters
WBC  15,000 cells/uL 2 (1) 55 (87) < 0.001
SCr  1.5 times the baseline 1 (1) 13 (21) < 0.001
Albumin < 2.5 mg/dL 19 (12) 25 (40) < 0.001
Healthcare exposure within past 90 d
Prior hospitalization 134 (83) 54 (86) 0.649
Long term care exposure 77 (48) 24 (38) 0.188
Hospital unit at time of diagnosis
Intensive care unit 11 (7) 12 (19) 0.004 a
Medical Ward 80 (50) 32 (50)
Long term care 27 (17) 6 (1)
Spinal cord unit 26 (16) 2 (3)
Cardiac intervention unit 4 (3) 5 (8)
Acute rehab unit 13 (7) 6 (10)
Prior tube feedings 24 (15) 7 (11) 0.459
Prior GI interventions 56 (35) 15 (24) 0.113
Medication use with in past 90 d
Antibiotic use 142 (88) 56 (89) 0.119
3 antibiotics used 55 (34) 30 (48) 0.041
H2RAs 16 (10) 9 (14) 0.353
PPIs 101 (63) 32 (51) 0.102
Antiperistaltics 3 (2) 2 (3) 0.622
Steroids 24 (15) 13 (20) 0.299
Immunosuppressives 48 (30) 18 (28) 0.855
Comorbidities
Diabetes 73 (45) 27 (43) 0.737
Renal insufﬁciency 49 (30) 21 (33) 0.674
Malignancy 55 (34) 24 (38) 0.580
Pulmonary disease 31 (19) 15 (24) 0.448
Cardiovascular disease 152 (94) 58 (92) 0.514
Treatment outcomes
Relapse in 60 d 19 (12) 9 (14) 0.613
Treatment failure 21 (13) 13 (21) 0.115
All-cause mortality in 30 d 17 (11) 20 (32) < 0.001
All-cause mortality in 31e90 d 5 (3) 4 (6) 0.273
All-cause mortality in 90 d 22 (14) 24 (38) < 0.001
Data are presented as n (%).
CDI¼ Clostridium difﬁcile infection; GI ¼ gastrointestinal; H2RAs ¼ histamine-2 receptor antagonists; PPIs ¼ proton-pump inhibitors; SCr ¼ serum creatinine; WBC ¼ whilte
blood count.
a Comparison of subgroups.
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severe CDI (odds ratio 2.39, conﬁdence interval 1.28e4.50,
p ¼ 0.006). Comparisons of treatment outcomes of relapse in 60
days and treatment failures between the two groups were notTable 3
Logistic regression analysis of the association between advanced age, multiple
antibiotic use, and proton-pump inhibitor use.
Odds ratio (95% conﬁdence interval) p
Age only (y)
70 2.43 (1.31e4.50) 0.005
Age and antibiotic use
70 y 2.34 (1.26e4.37) 0.007
3 antibiotics used 1.77 (0.96e3.23) 0.065
Age, antibiotic use, and proton pump-inhibitor use
70 y 2.38 (1.27e4.46) 0.007
3 antibiotics used 1.88 (1.01e3.47) 0.045
Proton-pump inhibitor use 0.56 (0.304e1.03) 0.063shown to be signiﬁcant (p ¼ 0.613, p ¼ 0.115, respectively). A sta-
tistically signiﬁcant difference was found in all-cause mortality at
30 days (32% severe CDI, 11% nonsevere CDI, p < 0.001) as well as 90
days (38% severe CDI, 14% nonsevere CDI, p < 0.001).4. Discussion
The current study evaluated the relationship between advanced
age and severity of CDI, and the ﬁndings suggest an association
between advanced age (70 years old) and incidence of severe CDI,
as deﬁned in the SHEA and IDSA treatment guidelines, in a veteran
population. These results were further conﬁrmed with the logistic
regression analysis. In addition, multiple (3) antibiotic use was
found to be an independent risk factor for severe CDI in the same
analysis. Of interest, a greater proportion of patients were diag-
nosed with severe CDI in the ICU. However, this may not be sur-
prising as those in the ICU are generally more unwell and likely
U.C. Patel et al. / Journal of Clinical Gerontology & Geriatrics 7 (2016) 12e16 15have other reasons for higher WBC and SCr levels, which were the
parameters used in this study to deﬁne severe CDI. As a result, it is
difﬁcult to determine whether the location itself or the patient's
current clinical state played a role in the severity of CDI. Interest-
ingly, therewas not a statistical difference noted between the study
groups when comparing recent hospitalization or exposure to long-
term care or nursing facilities within the 90 days prior to onset of
CDI.
It is believed that elderly patients are unable to mount an
appropriate humoral immune response, increasing the risk of a
more severe disease with poorer outcomes.5 Several prospective
and retrospective trials have looked into factors, including
advanced age, as being contributors to the severity of CDI.5e10 In a
15-month prospective cohort study, Loo et al6 found that for each
year of age > 18 years, the risk of health care-acquired CDI
increased by 2%. However, severity of infection was not speciﬁcally
evaluated in this study. Concurrent medications are another factor
that has been evaluated. Broad-spectrum antibiotics alter the
colonic ﬂora creating an environment for C. difﬁcile to ﬂourish.
Dharmarajan et al7 found patients to be at increased risk for severe
CDI when they were using three or more antibiotics before onset of
CDI or had any prolonged use (>4 weeks) of antibiotics prior to
diagnosis. However, a number of studies have also found no as-
sociation between the number of antibiotics used and disease
severity.5,10 In addition, the use of steroids and antiperistaltic
medications have been associated with severe CDI, however, these
ﬁndings have been challenged.8,10 Certain comorbidities may pose
another risk for severe CDI. Kyne et al11 found that four or more
comorbidities in a patient were associated with severe CDI, how-
ever, this ﬁnding did not reach statistical signiﬁcance. In this study,
severe disease was deﬁned as diarrhea lasting longer than 10 days
or associated with a complicated course (i.e., toxic megacolon or
fulminant pseudomembranous colitis). Other studies have also
evaluated individual illnesses (pulmonary disease, cardiovascular
disease, diabetes, malignancy, chronic renal insufﬁciency) in rela-
tion to disease severity, but the results have been contradicting.
Lungulescu et al10 conducted a retrospective review on 255 patient
cases looking at individual diseases that may be related to severe
CDI. Severe disease was deﬁned as patients requiring critical care
monitoring and/or colectomy, hospital stay > 10 days, or death
during hospitalization from CDI as the sole etiology. When
comparing co-existing diseases, there were a higher proportion of
severe CDI cases in patients with malignancy but not pulmonary
disease, chronic renal failure, or diabetes. Dudukgian et al9 also
conducted a similar study that reported pre-existing renal disease
and pulmonary disease as risk factors for increased mortality, but
not malignancy. In another study, Rao et al12 sought to evaluate the
role of impaired functional status as a risk factor for severe CDI in
elderly patients. Functional status was assessed according to ability
to perform activities of daily living categorized as independent,
some assistance, and full assistance. In both univariate and
multivariable analyses, activities of daily living requiring full
assistance was found to be an independent risk factor for severe
CDI.
GI intervention has also been identiﬁed as a risk factor for severe
CDI. Kyne et al11 found that the use of any GI instrumentation
(colonoscopy, sigmoidoscopy, endoscopy) was associated with a
fourfold increase in risk of severe disease comparedwith thosewho
did not undergo any of these procedures. Although nasogastric tube
feedings have also been shown to increase mortality in CDI, Dhar-
marajan et al7 and Bishara et al8 found no relationship between
disease severity and nasogastric feeding. It is important to note that
the deﬁnition of CDI severity differed among the mentioned
studies, thus results should be interpreted carefully and applied to
the appropriate patient populations.A limitation of this study is the retrospective study design,
which does not allow for optimal control of different variables. The
study also had a small sample size. A larger sample size may have
been able to better predict whether a speciﬁc risk factor had an
association with severe CDI. Another limitation is that patients
were not stratiﬁed by community or hospital-associated CDI. A
recent report from the Journal Watch of Gastroenterology reported
that those with community-acquired CDI were younger, healthier,
and less likely to have antibiotic exposure.13 As a result,
community-acquired cases may be associated with less severe CDI.
In addition, this study did not document speciﬁc medication
exposure dates, speciﬁcally antimicrobial and proton-pump inhib-
itor use, in relation to the onset of CDI. Although, a 30-day period
prior to CDI diagnosis may have been a better predictor for severity,
a 90-day period was chosen to avoid missing any medication use.
Finally, in the elderly population it is well established that an in-
crease in SCr may be more prevalent than in a younger population
due to physiological factors, thus serving as a confounding factor in
determining the impact of age on the severity of CDI. However, this
criteria was chosen based on literature indicating increased SCr to
be a predictor for more severe disease which is in turn reﬂected in
the IDSA/SHEA national guidelines.1 It is difﬁcult to determine if age
would still remain a signiﬁcant contributor to severe disease if
other criteria were used for identifying severe CDI cases.
Further prospective studies are warranted to better deﬁne the
association between various factors, including advanced age, and
severity of CDI. These studies should also ideally incorporate
C. difﬁcile strain typing when evaluating risk factors for severity of
disease. Those with the hypervirulent NAP1-BI strain may be at risk
for severe CDI, thus warranting more aggressive treatment. Finally,
incorporating the Charlson comorbidity index may help predict the
10-year risk of mortality for a patient. Pending further data, it may
be possible to identify those at highest risk for developing severe
CDI, thereby intervening early in hopes of preventing
complications.
Conﬂicts of interest
All contributing authors declare no conﬂicts of interest.
References
1. Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, et al. Clinical
practice guidelines for Clostridium difﬁcile infection in adults: 2010 update by
the society for healthcare epidemiology of America (SHEA) and the Infectious
Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010;31:
431e55.
2. Barlett JG. Antibiotic-associated colitis. Dis Mon 1984;30:1e54.
3. Potter VA, Aravinthan A. Identifying patients at risk of severe Clostridium
difﬁcile-associated disease. Br J Hosp Med 2012;73:265e70.
4. Henrich TJ, Krakower D, Bitton A, Yokoe DS. Clinical risk factors for severe
Clostridium difﬁcile-associated disease. Emerg Infect Dis 2009;15:415e21.
5. Andrew CN, Raboud J, Kassen BO, Enns R. Clostridium difﬁcile-associated diar-
rhea: predictors of severity in patients presenting to the emergency depart-
ment. Can J Gastroenterol 2003;17:369e73.
6. Loo VG, Bourgault AM, Poirier L, Lamothe F, Michaud S, Turgeon N, et al. Host
and pathogen factors for Clostridium difﬁcile infection and colonization. N Engl
J Med 2011;365:1693e703.
7. Dharmarajan T, Sipalay M, Shyamsundar R, Norkus E, Pitchumoni C. Co-
morbidity, not age predicts adverse outcome in Clostridium difﬁcile colitis.
World J Gastroenterol 2000;6:198e201.
8. Bishara J, Peled N, Pitlik S, Samra Z. Mortality of patients with antibiotic-
associated diarrhoea: the impact of Clostridium difﬁcile. J Hosp Infect 2008;68:
308e14.
9. Dudukgian H, Sie E, Gonzales-Ruiz C, Etzioni DA, Kaiser AM. C. difﬁcile col-
itisdpredictors of fatal outcome. J Gastrointest Surg 2010;14:315e22.
10. Lungulescu OA, Cao W, Gatskevich E, Tlhabano L, Stratidis JG. CSI: a severity
index for Clostridium difﬁcile infection at the time of admission. J Hosp Infect
2011;79:151e4.
11. Kyne L, Merry C, O'Connell B, Kelly A, Keane C, O'Neill D. Factors associated
with prolonged symptoms and severe disease due to Clostridium difﬁcile. Age
Ageing 1999;28:107e13.
U.C. Patel et al. / Journal of Clinical Gerontology & Geriatrics 7 (2016) 12e161612. Rao K, Micic D, Chenoweth E, Deng L, Galecki AT, Ring C, et al. Poor functional
status as a risk factor for severe Clostridium difﬁcile infection in hospitalized
older adults. J Am Geriatr Soc 2013;61:1738e42.13. Khanna S, Pardi DS, Aronson SL, Kammer PP, Orenstein R, St Sauver JL, et al. The
epidemiology of community-acquired Clostridium difﬁcile infection: a
population-based study. Am J Gastroenterol 2012;107:89e95.
